Pfizer expects sales to be in the range of $53 billion to $53.7 billion, compared with $53 billion to $55 billion as previously guided. "Pfizer Narrows Guidance on Tougher Pricing, Generic Competition," at 7:26 a.m. ET, incorrectly said Pfizer expected sales to be in the range of $53 billion to $55 billion, compared with $53 billion to $53.7 billion as previously guided in the second paragraph. (Oct. 30, 2018)

(END) Dow Jones Newswires

October 30, 2018 08:29 ET (12:29 GMT)

Copyright (c) 2018 Dow Jones & Company, Inc.
Pfizer (NYSE:PFE)
Graphique Historique de l'Action
De Mar 2024 à Avr 2024 Plus de graphiques de la Bourse Pfizer
Pfizer (NYSE:PFE)
Graphique Historique de l'Action
De Avr 2023 à Avr 2024 Plus de graphiques de la Bourse Pfizer